Advancements and Uncertainties in the Treatment of Congenital CMV Disease
- 28 December 2025
- journal article
- review article
- Published by Wiley in Reviews in Medical Virology
- Vol. 36 (1) , e70093
Abstract
Congenital cytomegalovirus (CMV) is a large contributor to neurodevelopmental delay and non‐genetic related sensorineural hearing loss, which can often be delayed in onset. While a majority of CMV infections are asymptomatic in healthy children and adults, CMV infection of immunocompromised hosts and in utero infection in neonates can cause more clinically significant and potentially long‐term disease. Increased awareness of the significance of congenital CMV is reflected in the evolution of treatment recommendations over the past 20 years. Most therapeutic studies conducted thus far have focused on the treatment and outcomes of neonates with moderate to severe congenital CMV disease, while more recent studies have explored treatment for neonates and infants with CMV‐related isolated sensorineural hearing loss. This review focuses on the clinical significance and treatment of congenital CMV infection, as well as the potential role for universal newborn CMV screening.Keywords
This publication has 23 references indexed in Scilit:
- Evolving Concepts in Care for Congenital Cytomegalovirus (cCMV) Infection: Better Outcomes for More Babies!The Journal of Pediatrics, 2024
- Valganciclovir in Infants with Hearing Loss and Clinically Inapparent Congenital Cytomegalovirus Infection: A Nonrandomized Controlled TrialThe Journal of Pediatrics, 2024
- Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical TrialThe Journal of Pediatrics, 2024
- Congenital cytomegalovirus infectionSeminars in Perinatology, 2018
- Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: A quantitative assessmentJournal of Clinical Virology, 2008
- Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infectionReviews in Medical Virology, 2007
- New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infectionReviews in Medical Virology, 2007
- Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?Journal of Clinical Virology, 2006
- Early intervention after universal neonatal hearing screening: Impact on outcomesMental Retardation and Developmental Disabilities Research Reviews, 2003
- Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infectionsClinical Pharmacology & Therapeutics, 1993